About SK:
SK Life Science, Inc., the U.S. subsidiary of SK Biopharmaceuticals, is an innovative global pharmaceutical company focused on the research, development and treatment of central nervous system (CNS) disorders. The company has a pipeline of eight compounds in development for CNS disorders. For more information about SK life science, please visit us at, sklifescienceinc.com .
In 2020, SK life science received FDA approval for XCOPRI® (cenobamate tablets) CV.
For more information about XCOPRI®, please visit xcopri.com .
CONNECT WITH SK LIFE SCIENCE, INC.
Latest Sponsored Posts
Finding Strength on the “Road to Reduction”
Living with an epilepsy diagnosis means facing a road to reduction of seizures that’s rarely straight or smooth.… Read More
Strength and Resilience: Kailey and Alan’s Journey with Epilepsy
Kailey and her father Alan’s journey with epilepsy has been one of perseverance and hope, marked by years of searching for the right treatment.… Read More
National Epilepsy Awareness Month: Why Advocacy Matters
November is National Epilepsy Awareness Month—a time to amplify the voices of the 3.4 million Americans living with epilepsy. Advocacy is crucial, helping to dispel myths and foster understanding. … Read More